Making Value-Based Healthcare in Cataract a Reality Insights from VBHCAT Pr...Alexandre Lourenço
Alexandre Lourenço's keynote on "Making Value-Based Healthcare in Cataract a Reality - Insights from VBHCAT Project in Portugal", at the 44th World Hospital Congress organized by the International Hospital Federation, in November 8th 2021.
Performance information and health system efficiency in FranceOECD Governance
This presentation was made by Ayden TAJAHMADY, France, at the 5th Meeting of the joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held on 4-5 February 2016 at the OECD Conference Centre in Paris.
Making Value-Based Healthcare in Cataract a Reality Insights from VBHCAT Pr...Alexandre Lourenço
Alexandre Lourenço's keynote on "Making Value-Based Healthcare in Cataract a Reality - Insights from VBHCAT Project in Portugal", at the 44th World Hospital Congress organized by the International Hospital Federation, in November 8th 2021.
Performance information and health system efficiency in FranceOECD Governance
This presentation was made by Ayden TAJAHMADY, France, at the 5th Meeting of the joint OECD DELSA/GOV Network on Fiscal Sustainability of Health Systems held on 4-5 February 2016 at the OECD Conference Centre in Paris.
How accurate urine collection = £1.2bn savings for the NHS.Giovanna Forte
We've done our research, which tells us that current unreliable urine collection means that 14,627,025 patients will fail to be accurately treated each year.
The large volumes of data and biosignals produced by the ICU overwhelm doctors and nurses, and do little to help them set priorities for the activities required in these units.
White Paper - Infection Preventionists: Healthcare’s Guardians at the Gate Ne...Q-Centrix
This white paper examines a key player at the front lines of hospitals’ never-ending battles against HAIs –Infection Preventionists (IPs). It briefly explains their varied roles, responsibilities and new challenges, the difficulty in recruiting these highly sought-after experts, and why and how hospitals should be doing more to help overworked and understaffed IPs be successful. Lastly, it covers new technologies and IP support services that can be integrated into hospitals’ infection control practices.
SPOTLIGHT ON THE PREMIUM CHANNEL – Bausch + LombHealthegy
Presentation from OIS@ASCRS 2016
Andrew Chang, General Manager & VP, US Surgical
Video Presentation:
https://www.youtube.com/watch?v=xxXQ5IKIMn8&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=36
Patient Registries: A New Pillar of Modern CareQ-Centrix
www.q-centrix.com
A vital resource for patient data are registries. This white paper examines the rise of patient registries, how hospitals are taking advantage of the data, the challenges hospitals face in submitting quality information, and the benefits of real-time registry reporting.
Guide to CMS Comprehensive Care for Joint Replacement modelQ-Centrix
On April 1, the CMS Comprehensive Care for Joint Replacement (CCJR) model went into effect for nearly 800 hospitals in 67 markets nationwide. Essentially, CMS converted its voluntary payment model—Bundled Payment for Care Improvement (BPCI)—into a regulatory mandate that will hold hospitals accountable for spending by all healthcare providers for 90 days following the initial episode of care.
Ayo Akinrinmade, Information Scientist at Orphanet, spoke in the 'Current initiatives in rare diseases' panel at the Cambridge Rare Disease Summit 2015.
How Effective is the Public in Influencing HTA Decisions?Kathi Apostolidis
Patients should be involved in HTA process to assure a robust process that embraces patients' needs, preferences, perspectives. ECPC-European Cancer Patient Coalition leverages on European Institutions for a solution to the timely authorization and reimbursement of innovative cancer medicines
Ομιλία-Παρουσίαση: Δώρα Τουρτόγλου, Clinical Research Manager, Ιατρικό Τμήμα, AstraZeneca Ελλάς
«Επενδύοντας στις κλινικές μελέτες στην Ελλάδα της κρίσης : Το παράδειγμα της ΑstraΖeneca Ελλάδας»
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...TITA research
Aaltonen, Heino, Ahola & Martikainen: Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimulation study. Presentation at TITA Annual Research Meeting 15.-16.9.2016.
How accurate urine collection = £1.2bn savings for the NHS.Giovanna Forte
We've done our research, which tells us that current unreliable urine collection means that 14,627,025 patients will fail to be accurately treated each year.
The large volumes of data and biosignals produced by the ICU overwhelm doctors and nurses, and do little to help them set priorities for the activities required in these units.
White Paper - Infection Preventionists: Healthcare’s Guardians at the Gate Ne...Q-Centrix
This white paper examines a key player at the front lines of hospitals’ never-ending battles against HAIs –Infection Preventionists (IPs). It briefly explains their varied roles, responsibilities and new challenges, the difficulty in recruiting these highly sought-after experts, and why and how hospitals should be doing more to help overworked and understaffed IPs be successful. Lastly, it covers new technologies and IP support services that can be integrated into hospitals’ infection control practices.
SPOTLIGHT ON THE PREMIUM CHANNEL – Bausch + LombHealthegy
Presentation from OIS@ASCRS 2016
Andrew Chang, General Manager & VP, US Surgical
Video Presentation:
https://www.youtube.com/watch?v=xxXQ5IKIMn8&list=PL1dmdBNnPTZJBhQxPOp0vdNg3s3wtN2yw&index=36
Patient Registries: A New Pillar of Modern CareQ-Centrix
www.q-centrix.com
A vital resource for patient data are registries. This white paper examines the rise of patient registries, how hospitals are taking advantage of the data, the challenges hospitals face in submitting quality information, and the benefits of real-time registry reporting.
Guide to CMS Comprehensive Care for Joint Replacement modelQ-Centrix
On April 1, the CMS Comprehensive Care for Joint Replacement (CCJR) model went into effect for nearly 800 hospitals in 67 markets nationwide. Essentially, CMS converted its voluntary payment model—Bundled Payment for Care Improvement (BPCI)—into a regulatory mandate that will hold hospitals accountable for spending by all healthcare providers for 90 days following the initial episode of care.
Ayo Akinrinmade, Information Scientist at Orphanet, spoke in the 'Current initiatives in rare diseases' panel at the Cambridge Rare Disease Summit 2015.
How Effective is the Public in Influencing HTA Decisions?Kathi Apostolidis
Patients should be involved in HTA process to assure a robust process that embraces patients' needs, preferences, perspectives. ECPC-European Cancer Patient Coalition leverages on European Institutions for a solution to the timely authorization and reimbursement of innovative cancer medicines
Ομιλία-Παρουσίαση: Δώρα Τουρτόγλου, Clinical Research Manager, Ιατρικό Τμήμα, AstraZeneca Ελλάς
«Επενδύοντας στις κλινικές μελέτες στην Ελλάδα της κρίσης : Το παράδειγμα της ΑstraΖeneca Ελλάδας»
Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimu...TITA research
Aaltonen, Heino, Ahola & Martikainen: Effects of the 2016 pharmaceutical reimbursement scheme changes – a microsimulation study. Presentation at TITA Annual Research Meeting 15.-16.9.2016.
Presentation during the 17th European AIDS Conference (EACS) 2019 looking at the status of HIV pre-exposure prophylaxis PrEP in Europe..
Presenter: Teymur Noori, European Centre for Disease Prevention and Control (ECDC)
Presentation by Daniel Simões, HIV in Europe, Portugal , at AIDS 2018 conference during the joint ECDC and EACS satellite "Getting to 90: Addressing inequalities in the HIV continuum of care in Europe and Central Asia"
Presentation delivered by OECD Secretary-General Angel Gurría for the joint launch of the 2018 Environmental Performance Review and Economic Survey of the Czech Republic.
Presented at the 66th session of the WHO Regional Committee for Europe by:
Dr Oleg Chestnov, Assistant Director-General, WHO
Dr Jill Farrington, Acting Head, NCD Project Office, Moscow
Dr Gauden Galea, Director, Noncommunicable Diseases and
Promoting Health through the Life-course, WHO/Europe
INSTITUTION FACTORS AFFECTING ADHERENCE TO NATIONAL PRESSURE ULCER PREVENTION...AM Publications
Pressure ulcer prevention guidelines can reduce the incidence and prevalence of pressure ulcers if properly adhered to. A descriptive cross-sectional study was done among 200 nurses working in the main government hospital in Embu. A sample of 145 nurses was selected using stratified random sampling and systematic random sampling methods. Data was collected using a self administered questionnaire developed from the Nursing Council of Kenya (NCK) manual of clinical procedures. Data was analysed using IBM SPSS Version 21 software. Most nurses (64.4%) reported the hospital had no policy on pressure ulcer prevention while 35.6% said it was there, 13.6% attended continuous professional development (CPD) sessions on pressure ulcer prevention while 86.4% did not, 55.9% reported that pressure relief devices were provided while 44.1% said none was provided and on perceived staffing levels, 3.4% felt the hospital was adequately staffed, 46.6% understaffed and 50% grossly understaffed. There was a significant association between hospital policy, attendance of CPD and perceived staffing levels with adherence to the Nursing Council of Kenya (NCK) pressure ulcer prevention guidelines (p=<0.05)
Presentation at PORTAGE (Paediatric Oncology Roundtable to Transform Access to Global Essentials) Inaugeral Meeting, hosted by Friends of Cancer Patients, Childhood Cancer International and International Society of Paediatric Oncology, 16-18 January 2018, Sharjah, UAE
Similar to Reducing Unnecessary Caesarean Sections in the WHO European Region (20)
Alexandre Lourenço's keynote on "Better Quality for Better Hospitals", at the 42nd World Hospital Congress, organized by International Hospital Federation, Lisbon 27th of October 2023.
Alexandre Lourenço's keynote on "Managing TB, HIV and viral hepatitis in Primary care", at the international conference "Primary health care policy and practice: implementing for better results", organized by WHO/Europe, together with UNICEF and the Government of Kazakhstan, 2023.
Alexandre Lourenço's keynote on "How data can be used for NCDs? Case Studies", at the Second WHO symposium on the future of health systems in a digital era in the WHO European Region: 5-6 September 2023, Porto, Portugal.
Conferência de Alexandre Lourenço sobre "Liderança e Motivação de Equipas", proferida na Cerimónia de Comemoração do Dia Internacional do Enfermeiro do Centro Hospitalar e Universitário de Coimbra, a 12 de maio de 2023.
Administração Hospitalar no séc. XXI: O que nos falta?Alexandre Lourenço
Conferência de Alexandre Lourenço sobre "Administração Hospitalar no séc. XXI: O que nos falta?", proferida nas Conferências de Valor da Associação Portuguesa de Administradores Hospitalares, a 25 de março de 2023. A conferência pode ser vista aqui: https://youtu.be/v4YulXVTC-g
Alexandre Lourenço's keynote on "Planning for a modern workforce", at the WHO High-level Regional Meeting on Health and Care Workforce in Europe: 22-23 March 2023, Bucharest, Romania.
Alexandre Lourenço's keynote on "To be high-value
care or not to be — How to lose high-value care in ten steps", at the EIT Health Matchmaking event, 6th December 2022, Tallin, Estonia.
Alexandre Lourenço's keynote on "Key Challenges facing European Healthcare" at the Health Management Institute of Ireland (HMI) Annual Conference in Dublin (2-Nov-2022).
Alexandre Lourenço's Keynote on "Ten steps for everything remains the same - opportunities for hospital's engagement". The keynote was part of the Health InnovAction, that took place in Bologne - Morning Health Talks launched by the EIT Health Regional Innovation Scheme e organizadas pela ART-ER, Bio Check Up S.r.l., Synlab SDN S.p.a. em novembro de 2022.
Conferência de Alexandre Lourenço sobre a gestão pós-pandemia, no âmbito do Fórum Equidade e Acessibilidade na Era COVID-19, organizado pela Sociedade Portuguesa de Cardiologia (SPC), a 11 de fevereiro de 2022 no Centro Cultural de Belém, Lisboa.
Alexandre Lourenço's keynote on "Managerial Skills That Will Help You Make A Difference", at the Improving Cancer Outcomes and Leadership course: an ESO, ECO and SPCC European Initiative, 8th July 2022, Warsaw, Poland.
Conferência online de Alexandre Lourenço sobre a importância de planear em saúde ao nível da gestão intermédia, na âmbito do PADIS online, AESE - Escola de Negócios, 14 de julho de 2022.
Conferência de Alexandre Lourenço sobre recuperação da atividade assistencial pos-covid, na âmbito da Convenção Nacional de Saúde, Ordem dos Médicos, 20 de abril de 2022.
Alexandre Lourenço's keynote on "WHAT NOW? Health management after COVID-19", at the SDA Bocconi #MIHMEP graduation ceremony, 25 February 2022, Milan, Italy.
Hospital management: Patient-centered care, CEO appointments and their impactAlexandre Lourenço
Alexandre Lourenço's Ph.D. defense on "Hospital management: Patient-centered care, CEO appointments and their impact". A thesis carried out on the Ph.D. Program in Management of Nova School of Business and Economics, 31st January 2022.
under the supervision of
Professor Pedro Pita Barros
Alexandre Lourenço's keynote on "Supportive partnerships for healthcare quality", at the WHO/Europe “Meeting of Minds” on ensuring quality of care post-COVID-19, 2–3 December 2021, Athens, Greece.
Modalidades de pagamento - o caso do acidente vascular cerebralAlexandre Lourenço
Apresentação sobre "Modalidades de Pagamento", realizada durante a 12ª Reunião Nacional de Unidades de AVC, no dia 24 de setembro de 2021, organizada pela Sociedade Portuguesa do Acidente Vascular Cerebral.
Statistics to achieve healthcare 2.0 is an Alexandre Lourenço's Keynote presented on July 22nd 2021, at the 3rd Statistics on Health Decision Making, organized by Universidade de Aveiro, Portugal.
Novo modelo para a integração de cuidados no envelhecimentoAlexandre Lourenço
Apresentação sobre "Novo modelo para a integração de cuidados no envelhecimento", realizada em Coimbra, no dia 18 de julho de 2021, no âmbito da Conferência Envelhecimento e Temas Tecnológicos Associados, organizada pela Fundação Amélia de Mello e Universidade de Coimbra.
Comunicação de Alexandre Lourenço realizada no âmbito do ciclo “Fins de tarde na cidade. Novas perspetivas para o futuro da saúde em Portugal", realizada no dia 25 de maio de 2021, pelo Instituto Superior de Ciências Sociais e Políticas da Universidade de Lisboa.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
Best Ayurvedic medicine for Gas and IndigestionSwastikAyurveda
Here is the updated list of Top Best Ayurvedic medicine for Gas and Indigestion and those are Gas-O-Go Syp for Dyspepsia | Lavizyme Syrup for Acidity | Yumzyme Hepatoprotective Capsules etc
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva.
Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade.
Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal.
Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural.
Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis.
É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais.
O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada.
Recomendamos muito.
Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos.
Esta publicação só está disponível em inglês até o momento.
Prof. Marcus Renato de Carvalho
www.agostodourado.com
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
263778731218 Abortion Clinic /Pills In Harare ,sisternakatoto
263778731218 Abortion Clinic /Pills In Harare ,ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group ABORTION WOMEN’S CLINIC +27730423979 IN women clinic we believe that every woman should be able to make choices in her pregnancy. Our job is to provide compassionate care, safety,affordable and confidential services. That’s why we have won the trust from all generations of women all over the world. we use non surgical method(Abortion pills) to terminate…Dr.LISA +27730423979women Clinic is committed to providing the highest quality of obstetrical and gynecological care to women of all ages. Our dedicated staff aim to treat each patient and her health concerns with compassion and respect.Our dedicated group of receptionists, nurses, and physicians have worked together as a teamof receptionists, nurses, and physicians have worked together as a team wwww.lisywomensclinic.co.za/
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Reducing Unnecessary Caesarean Sections in the WHO European Region
1. Reducing Unnecessary Caesarean Sections
in the WHO European Region
13-14 December 2018 Tbilisi, Georgia
Alexandre Lourenço
WHO Consultant on Health Systems Strengthening & Financing
Hospital Administrator/ Coimbra University Hospital
PhD candidate/ Nova School of Business & Economics
President/ Portuguese Association of Hospital Managers
Board Member/ European Association of Hospital Managers
2. Outline
• The current situation
• Drivers behind unnecessary C-
sections in caesarean sections
• Moving forward
• Country examples
11. Unnecessary
C-sections
Mother
preferences
Labour pain and fear
Healthier for the baby
Plastic interest
Convenience
Physicians’
perceptions and
behaviour
Defensive medicine
Convenience
Financial incentives
Providers
behaviour
Staffing models of delivery care
Financial incentives
Poor health literacy
Inadequate care delivery
Litigation & liability premiums
Lack of skills/ competencies
Inadequate care organization/ work
conditions
Unclear guidelines/ algorithms
Inadequate financial incentives
Absent facilities licensing
Fragmented care
Inadequate financial incentives
Absent or unclear delivery care model
12. Acknowledge
•Raise evidence
•Priority health policy
Inform
•Benchmarking
•Making information
public can
effectively support
behaviour change
Pay
•Payment systems
•e.g. single tariff,
P4P, penalty tariff
Persuade
•Non-clinical
educational
interventions
•evidence-based
clinical practice
guidelines combined
with mandatory
second opinion for
caesarean indication
•clinical guidelines,
audit, feedback
•Supporting tools
(e.g. decision aids)
Source:
based
on
OECD,
2017
13. Country setting
& development status
Other sectors:
education,
sanitation,
social assistance,
labour, housing,
environment
& others
Conceptual framework of integrated people-centred health
services
13
Health
sector:
governance,
financing &
resources
<
Service delivery:
Networks,
Facilities &
practitioners
PERSON
increase health care costs
Petrou S, Glazener C. The economic costs of alternate modes of delivery during the first two months postpartum: results from a Scottish observational study. BJOG 2002;109:214–7.
Persuade:
importance of behavior change
Public campaigns
Combined with individual-level interventions:
Integrated people-centred health services (IPCHS) are a key feature of robust and resilient health systems and are critical for progressing towards universal health coverage (UHC) and the Sustainable Developmental Goals (SDGs).
The Framework for integrated people-centred health services was agreed by our ministers at the World Health Assembly in 2016.
This approach consciously adopts individuals’, carers’, families’ and communities’ perspectives as participants in, and beneficiaries of, trusted health systems
Health systems are organized around the comprehensive needs of people rather than individual diseases, and respects social preferences patients have the education and support they need to make decisions and participate in their own care
Carers are able to attain maximal function within a supportive working environment
It is broader than patient and person-centred care, encompassing not only clinical encounters, but also including attention to the health of people in their communities and their crucial role in shaping health policy and health services